🔴 Cerenome is trading 8.91% down in after-hours trading after reporting a $9.0 million Q2 net loss

Cerenome is trading 8.91% down at $3.35 in after-hours trading after releasing second-quarter results on August 14, 2026.

• Q2 net loss was $9.0 million, or $1.31 per share, with $411,000 in revenue; external coverage characterized the quarter as missing analyst expectations.
• Operating losses expanded to $9.1 million from $1.5 million year over year, while cash, equivalents, and investments totaled $8.6 million.
• Cerenome reaffirmed its 2026 milestone framework; weak results likely drove after-hours selling.